United States Patent Act

United States Patent Act
Name	United States Patent Act
Jurisdiction	United States
Enacted	1790s–present
Primary authority	United States Code
Citation	Title 35
Related legislation	Patent Cooperation Treaty, Leahy–Smith America Invents Act

United States Patent Act is the primary statutory framework governing patent law in the United States, codified principally at Title 35 of the United States Code. It structures the grant, prosecution, validity, and enforcement of patents for inventions and designs, interacting with international instruments and adjudicative bodies. The Act has evolved through landmark statutes, judicial decisions, and administrative rules that have shaped patenting across technology sectors and industries.

History and Legislative Development

The statutory roots trace to the early federal period and the enactment of the first patent statutes under the United States Congress during the Presidency of George Washington era, followed by foundational revisions such as the Patent Act of 1793 and the Patent Act of 1836. Subsequent major reforms include the Patent Act of 1952, which codified key doctrines into Title 35, and the transformative Leahy–Smith America Invents Act enacted by the 111th United States Congress during the Presidency of Barack Obama. Judicial interpretations by the United States Supreme Court, including decisions in Diamond v. Chakrabarty, Alice Corp. v. CLS Bank International, KSR International Co. v. Teleflex Inc., and Bobbs-Merrill Co. v. Straus-era jurisprudence, have influenced statutory application. Administrative design and rulemaking by the United States Patent and Trademark Office and review processes established by the Patent Trial and Appeal Board reflect interactions with international regimes such as the Paris Convention for the Protection of Industrial Property and the Patent Cooperation Treaty.

Scope and Subject Matter Eligibility

Title 35 defines patentable subject matter, intersecting with key rulings like Diamond v. Chakrabarty and Mayo Collaborative Services v. Prometheus Laboratories, Inc. that addressed biotechnology and diagnostic methods. The Act distinguishes categories such as processes, machines, manufactures, and compositions of matter, while exclusions and threshold tests were elaborated in Alice Corp. v. CLS Bank International for software and business method claims. Interplay with standards from the World Intellectual Property Organization and treaties like the Agreement on Trade-Related Aspects of Intellectual Property Rights affects eligibility for inventors seeking protections across jurisdictions represented by organizations such as the European Patent Office and national offices like the Japan Patent Office and United Kingdom Intellectual Property Office.

Patentability Requirements (Novelty, Nonobviousness, Enablement)

Statutory criteria in Title 35 require claims to satisfy novelty, nonobviousness, and enablement. Novelty standards have been shaped by cases such as Graham v. John Deere Co. and statutory provisions influenced by prior art regimes adopted under the Leahy–Smith America Invents Act moving to a first-inventor-to-file system discussed in debates in the United States Senate. Nonobviousness inquiries reference KSR International Co. v. Teleflex Inc. for flexible analysis against prior art, while enablement and written description obligations invoke precedents including Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co. and In re Wands. Patent sections also engage with experimental use exemptions considered in litigation involving entities like Merck & Co. and Genentech, Inc..

Application, Examination, and Prosecution Procedures

Procedural aspects under the Act govern filing, prosecution, and examination at the United States Patent and Trademark Office, overseen historically by the Commissioner of Patents and presently by the Under Secretary of Commerce for Intellectual Property. The Act permits provisional applications, continuations, and the Patent Cooperation Treaty route administered with assistance from the World Intellectual Property Organization. Examination uses search practices, office actions, and appeals to the Patent Trial and Appeal Board, with further judicial review at the United States Court of Appeals for the Federal Circuit and the United States Supreme Court. Fee structures and maintenance requirements reflect policy inputs from the United States Department of Commerce and congressional oversight by committees such as the House Committee on the Judiciary and the Senate Committee on the Judiciary.

Rights, Remedies, and Enforcement

Patent rights under Title 35 confer exclusionary rights enforced through civil litigation in federal district courts and appeals to the United States Court of Appeals for the Federal Circuit. Remedies include injunctive relief and damages, with standards influenced by decisions like eBay Inc. v. MercExchange, L.L.C. on injunctive discretion and TC Heartland LLC v. Kraft Foods Group Brands LLC on venue. Administrative remedies include inter partes review and covered business method review at the Patent Trial and Appeal Board, with estoppel consequences examined in cases such as SAS Institute Inc. v. Iancu and Oil States Energy Services, LLC v. Greene's Energy Group, LLC. Licensing regimes, assignments, and exhaustion doctrines have been litigated by entities including IBM, Microsoft Corporation, Apple Inc., and Qualcomm Incorporated.

Limitations, Exceptions, and Compulsory Licenses

The Act and its interpretation recognize statutory and judicial limitations such as experimental use doctrines, research exemptions debated in academia and industry, and sovereign immunity issues raised by Florida Prepaid Postsecondary Education Expense Board v. College Savings Bank. Compulsory licensing and government use provisions intersect with statutes and international obligations arising under treaties like TRIPS Agreement, and have been invoked in contexts involving public health and standards-essential patents where bodies such as the Federal Trade Commission or foreign governments (e.g., United Kingdom, India) influence policy. Immunities for certain noncommercial activities, statutory bars, and post-grant challenges provide mechanisms balancing private rights and public interests, with ongoing legislative and judicial activity shaping limitations.

Category:United States patent law